Efficacy and Safety of Biosimilar SAR342434 Insulin Lispro in Adults with Type 1 Diabetes Also Using Insulin Glargine—SORELLA 1 Study
-
- Satish K. Garg
- Barbara Davis Center for Diabetes, University of Colorado Denver, Aurora, Colorado.
-
- Karin Wernicke-Panten
- Sanofi-aventis Deutschland GmbH, Frankfurt, Germany.
-
- Maria Rojeski
- Sanofi, Bridgewater, New Jersey.
-
- Suzanne Pierre
- Sanofi, Paris, France.
-
- Yvonne Kirchhein
- Sanofi-aventis Deutschland GmbH, Frankfurt, Germany.
-
- Krystyna Jedynasty
- Centrum Diabetologiczne, Centralny Szpital Kliniczny MSW, Warsaw, Poland.
書誌事項
- 公開日
- 2017-09
- 権利情報
-
- http://www.liebertpub.com/nv/resources-tools/text-and-data-mining-policy/121/
- DOI
-
- 10.1089/dia.2017.0117
- 公開者
- SAGE Publications
この論文をさがす
収録刊行物
-
- Diabetes Technology & Therapeutics
-
Diabetes Technology & Therapeutics 19 (9), 516-526, 2017-09
SAGE Publications
